Serge Bureau
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 6
- Pharmaceutical Economics and Policy 2
-
- Ethics in Clinical Research 4
- Co-authors
- Tabassome Simon (3 shared papers)Matthieu Roustit (2 shared papers)Bruno Laviolle (2 shared papers)Catherine Cornu (2 shared papers)Jéhan‐Michel Béhier (2 shared papers)Eric Vicaut (2 shared papers)Silvy Laporte (2 shared papers)Michel Cucherat (2 shared papers)
- Journals
- EClinicalMedicine (2 papers)JAMA (1 paper)Annals of Internal Medicine (1 paper)JAMA Network Open (1 paper)JAMA Internal Medicine (1 paper)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Serge Bureau
17 papers receiving 1.5k citations
Serge Bureau's Hit Papers
Peers
Comparison fields: 5 of 100
- Infectious Diseases 884
- Neurology 425
- Critical Care and Intensive Care Medicine 59
- Applied Microbiology and Biotechnology 14
- Immunology 122
Countries citing papers authored by Serge Bureau
This map shows the geographic impact of Serge Bureau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serge Bureau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serge Bureau more than expected).
Fields of papers citing papers by Serge Bureau
This network shows the impact of papers produced by Serge Bureau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serge Bureau. The network helps show where Serge Bureau may publish in the future.
Co-authors
The 25 scholars most cited alongside Serge Bureau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia Hit paper breakdown → | 2020 | 589 |
| 2 | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 Hit paper breakdown → | 2021 | 501 |
| 3 | Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial Hit paper breakdown → | 2021 | 229 |
| 4 | 2023 | 56 | |
| 5 | 2019 | 30 | |
| 6 | 2018 | 21 | |
| 7 | 2022 | 18 | |
| 8 | 2017 | 17 | |
| 9 | 2024 | 8 | |
| 10 | 2022 | 6 | |
| 11 | 2017 | 5 | |
| 12 | 2024 | 4 | |
| 13 | 2018 | 3 | |
| 14 | 2022 | 2 | |
| 15 | 2024 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2019 | 1 |
About Serge Bureau
Serge Bureau is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health, Statistics and Probability, Pediatrics, Perinatology and Child Health and Infectious Diseases, having authored 17 papers that have together received 1.5k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Ethics in Clinical Research (4 papers), Statistical Methods in Clinical Trials (2 papers), Advanced Causal Inference Techniques (2 papers), Mobile Health and mHealth Applications (2 papers), Pharmaceutical studies and practices (2 papers), Pharmaceutical Economics and Policy (2 papers) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Infectious Diseases (884 citations), Neurology (425 citations), Critical Care and Intensive Care Medicine (59 citations), Applied Microbiology and Biotechnology (14 citations) and Immunology (122 citations). Serge Bureau has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Tabassome Simon, Matthieu Roustit, Bruno Laviolle, Catherine Cornu, Jéhan‐Michel Béhier, Eric Vicaut, Silvy Laporte, Michel Cucherat, Florence Binlich and Xavier Paolettí. Their work appears in journals such as EClinicalMedicine, JAMA, Annals of Internal Medicine, JAMA Network Open and JAMA Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.